Sanaya Gandhi, PA
Physician Assistant · Charlotte, NCNPI 1891385548
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.6%), speaking fees and education — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Galderma Laboratories, L.p. at 50.9% of the total. 2025 is the largest year on record at $19,799, more than ten times the $1,612 reported in 2022. Among physician assistant clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 757 payments — averaging $37.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$15K
- AbbVie$2K
- Sanofi$2K
- Johnson & Johnson$1K
- Dermavant Sciences, Inc.$1K
- Regeneron Healthcare Solutions, Inc.$1K
- plus $8K from 20 others
What the payments were for
- Speaking & faculty fees$13,20046%
- Travel & lodging$4812%
- Food & beverage$14,22850%
- Education$7803%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 83 | $14,615 |
| AbbVie | 98 | $1,569 |
| Sanofi | 53 | $1,543 |
| Johnson & Johnson | 62 | $1,246 |
| Dermavant Sciences, Inc. | 76 | $1,048 |
| Regeneron Healthcare Solutions, Inc. | 37 | $1,042 |
| Sun Pharmaceutical Industries Inc. | 46 | $999 |
| Arcutis Biotherapeutics, Inc. | 37 | $943 |
| LEO Pharma Inc. | 39 | $884 |
| UCB, Inc. | 31 | $857 |
| Lilly USA, LLC | 45 | $778 |
| E.r. Squibb & Sons, L.L.C. | 35 | $701 |
| Incyte Corporation | 26 | $502 |
| Pfizer | 29 | $392 |
| Amgen | 16 | $366 |
| Organon | 10 | $330 |
| Organogenesis Inc. | 2 | $261 |
| Novartis | 7 | $169 |
| Verrica Pharmaceuticals Inc. | 6 | $102 |
| Almirall LLC | 4 | $78 |
| Boehringer Ingelheim | 3 | $66 |
| Biofrontera Inc. | 3 | $50 |
| Botanix SB Inc | 3 | $46 |
| Journey Medical Corporation | 3 | $44 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $44 |
| Mayne Pharma Commercial LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$28,688 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 22 | $462,609 |
| Dupixent PenDupilumab | 46 | $179,114 |
| OtezlaApremilast | 35 | $176,193 |
| OpzeluraRuxolitinib Phosphate | 24 | $48,273 |
| AdbryTralokinumab-Ldrm | 11 | $42,584 |
| Clobetasol Propionate | 207 | $7,610 |
| EpsolayBenzoyl Peroxide | 13 | $7,576 |
| Tacrolimus | 43 | $5,416 |
| Ketoconazole | 240 | $4,104 |
| Triamcinolone Acetonide | 201 | $3,342 |
| Betamethasone Dipropionate | 51 | $3,033 |
| Clindamycin Phosphate | 88 | $2,792 |
| Fluorouracil | 35 | $2,653 |
| Halobetasol Propionate | 35 | $2,027 |
| Tretinoin | 22 | $1,851 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenOtezla | $366 | $176,19335 claims |
| Incyte CorporationOpzelura | $502 | $48,27324 claims |
| LEO Pharma Inc.Adbry | $884 | $42,58411 claims |
| Galderma Laboratories, L.p.Epsolay | $14,615 | $7,57613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Charlotte
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Kristin CabedaCharlotte$135K
- Meghan EmigCharlotte$124K
- Juleidy TurnipseedCharlotte$84K
- Erin SiceloffCharlotte$50K
- Ronald RodriguezCharlotte$31K
- Lamiaa TolbaCharlotte$29K
- Jacqueline LeyrerCharlotte$24K
- Mackenzie McArthurCharlotte$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.